glp-1/gip/glucagon triple agonist 🚨 Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and type 2 diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ longevity Sample collection:Walk-in clinic resM | GLP-1 Probiotic

glp-1/gip/glucagon triple agonist 🚨 Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and type 2 diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ longevity Sample collection:Walk-in clinic resM | GLP-1 Probiotic

resM | GLP-1 Probiotic

Clinical trials Enrolling in one of Eli Lilly TRIUMPH trials provides access to pharmaceutical-grade retatrutide at no cost, with full medical supervision

longevity

Sample collection:Walk-in clinic

Researchers reviewed data from nearly 2 million people treated by the Veterans Health Administration, including more than 216,000 patients prescribed GLP-1 medications